Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows

v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (40,198) $ (61,191)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 38,521 37,360
Share-based compensation expense 3,541 2,958
Provision for revenue adjustments 731 647
Deferred income tax benefit (2,170) (2,792)
Other 3,870 3,799
Changes in operating assets and liabilities:    
Accounts receivable 11,863 (21,145)
Other receivables 2,052 (434)
Other current and noncurrent assets (3,097) 767
Accounts payable and accrued expenses 30,625 67,646
Net cash provided by operating activities 45,738 27,615
Investing activities:    
Proceeds from sale of property and equipment 1,428 691
Purchases of property and equipment (6,946) (11,906)
Other 0 (24)
Net cash used in investing activities (5,518) (11,239)
Financing activities:    
Repayments of finance lease obligations (4,225) (4,431)
Proceeds from credit facility 0 25,000
Payments on credit facility 0 (25,000)
Payment of minimum tax withholdings on share-based awards and other (685) (894)
Net cash used in financing activities (4,910) (5,325)
Effect of exchange rate changes on cash (284) 357
Net increase in cash and cash equivalents 35,026 11,408
Cash and cash equivalents at beginning of period 105,996 105,266
Cash and cash equivalents at end of period $ 141,022 $ 116,674